Evidence map›Paper›PMID 29089790›Full record

ArticlePatient related outcome measures2017

A pilot study of subjective well-being in colorectal cancer patients and their caregivers.

Janet Graham, Pavlina Spiliopoulou, Rob Arbuckle, Julie Ann Bridge, James Cassidy

Open access · goldAbstract read
In one paragraph

Article in Patient related outcome measures, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Using a Chinese time trade-off approach to explore the health utility level and quality of life of cancer patients in urban China: a multicentre cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Janet GrahamDepartment of Medical Oncology, Beatson, West of Scotland Cancer Center, Glasgow, UK.
Pavlina SpiliopoulouDepartment of Medical Oncology, Beatson, West of Scotland Cancer Center, Glasgow, UK.
Rob ArbuckleAdelphi Values, Adelphi Mill Macclesfield, Cheshire, UK.
Julie Ann BridgeEli Lilly Pty Ltd., West Ryde, NSW, Australia.
James CassidyDepartment of Medical Oncology, Beatson, West of Scotland Cancer Center, Glasgow, UK.
Beatson West of Scotland Cancer Centre · GBAdelphi Group (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional endpoints in oncology are based on measuring the tumor size and combining this with a time factor. Current studies with immunotherapy show that even when median survival is unaltered, a significant proportion of patients can achieve prolonged survival. Objective tumor response does not always mean "overall" improvement, especially if toxicity is harsh. Novel agents are significantly expensive, and it is therefore crucial to measure the impact on "quality" of life, in addition to "quantity". MATERIALS AND

methodsWe studied the preferences and experiences of cancer patients and their caregivers, measuring subjective well-being (SWB) ratings, EQ5D descriptions and time trade-off preferences.

resultsWe studied 99 patients and 88 caregivers. Life satisfaction ratings were similar between the two groups, but daily mood was significantly lower in caregivers (

conclusionCaregivers are as anxious or depressed as patients, and report similar levels of life satisfaction but lower daily mood. A focus on SWB could provide a valid assessment of treatment benefit. Given the interesting results of this pilot study, we suggest a larger study should be conducted, measuring SWB over time.

Indexed as

day affectEQ5Dlife satisfactionsubjective well-beingTTO

Identifiers

PMID29089790
PMCPMC5656346
OpenAlexW2765757357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.